[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] # Alvotech Ordinary Shares (ALVO) Alvotech's stock price has seen a significant decline following an FDA Complete Response Letter for its AVT05 biosimilar and lowered FY25 guidance. This downturn is compounded by negative social media sentiment and recent financial institution downgrades, despite a recent European approval for Gobivaz. ### About Alvotech Ordinary Shares Alvotech Ordinary Shares (ALVO) is a publicly traded stock in the healthcare sector, focused on developing and manufacturing biosimilar medicines. Alvotech Ordinary Shares uses the ticker $ALVO for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors. ### Insights - Alvotech Ordinary Shares (ALVO) trading volume is up XXXXXX% from the previous week. - Alvotech Ordinary Shares (ALVO) market cap is up XXXXX% from the previous week. - Alvotech Ordinary Shares (ALVO) social dominance is up XX% from the previous week. - Alvotech Ordinary Shares (ALVO) Galaxy Scoreโข is up XXXXX% from the previous week. - Alvotech Ordinary Shares (ALVO) sentiment is up XXXXX% from the previous week. - Alvotech Ordinary Shares (ALVO) engagements is up XXXXXX% from the previous week. - Alvotech Ordinary Shares (ALVO) posts created is up XXX% from the previous week. ### Price: $XXXX  [Price 24-Hour Time-Series Raw Data](/topic/$alvo/time-series/close.tsv) The stock price has declined significantly due to an FDA Complete Response Letter for its AVT05 biosimilar and lowered FY25 guidance, exacerbated by negative social media sentiment and recent financial institution downgrades, despite recent European approval for Gobivaz. 24-Hour: XXXX% 7-Day: XXXXX% 30-Day: -XXXX% 1-Year High: $XXXXX on 2025-01-11 1-Year Low: $XXXX on 2025-12-02 ### AltRank: XXXXX  [AltRank 24-Hour Time-Series Raw Data](/topic/$alvo/time-series/alt_rank.tsv) Alvotech Ordinary Shares (ALVO) is currently AltRank #1,691 based on combined combined social and market metrics Daily Average: XXXXX X Week: XXXXX +51 X Month: XXXXX +756 X Months: XXXXX -XXX X Year: XXXXX +35 1-Year High: XXXXX on 2025-07-30 1-Year Low: XX on 2024-12-29 ### Galaxy Score: XXXXX  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$alvo/time-series/galaxy_score.tsv) Current Value: XXXXX Daily Average: XX X Week: XX +25 X Month: XX no change X Months: XX +26 X Year: XX +24 1-Year High: XX on 2025-09-23 1-Year Low: X on 2025-09-03 ### Engagements: XXX (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/$alvo/time-series/interactions.tsv) Current Value: XXX Daily Average: XXXXX X Week: XXXXX +178% X Month: XXXXXX -XX% X Months: XXXXXXX +132% X Year: XXXXXXXXX -XX% 1-Year High: XXXXXXX on 2025-08-13 1-Year Low: XX on 2025-04-20 Engagements by network (24h): Reddit: XX X: XXX ### Mentions: XX (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/$alvo/time-series/posts_active.tsv) Current Value: XX Daily Average: XX X Week: XXX +7.10% X Month: XXX -X% X Months: XXXXX +84% X Year: XXXXX +83% 1-Year High: XXX on 2025-06-30 1-Year Low: X on 2025-12-08 Mentions by network (24h): Reddit: XX X: XX ### Creators: XX (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/$alvo/time-series/contributors_active.tsv) XX unique social accounts have posts mentioning Alvotech Ordinary Shares (ALVO) in the last XX hours which is up XX% from X in the previous XX hours Daily Average: XX X Week: XX +7.60% X Month: XXX -XX% X Months: XXXXX +207% X Year: XXXXX +144% 1-Year High: XXX on 2025-06-30 1-Year Low: X on 2025-03-02 ### Sentiment: XX%  [Sentiment 24-Hour Time-Series Raw Data](/topic/$alvo/time-series/sentiment.tsv) Current Value: XX% Daily Average: XX% X Week: XX% +7% X Month: XX% -XX% X Months: XX% -XX% X Year: XX% +43% 1-Year High: XXX% on 2025-01-27 1-Year Low: X% on 2025-01-19 Most Supportive Themes: - Analyst Ratings and Upside Potential: (35%) Positive analyst ratings and potential for stock upside are contributing to positive sentiment. - Biosimilar Market Opportunity: (25%) The company's focus on biosimilar medicines and strategic partnerships are highlighted as key strengths and growth drivers. - Earnings and Financial Performance: (15%) Positive mentions of Alvotech's recent earnings report, including a swing to profit and strong revenue growth, are driving positive sentiment. Most Critical Themes: - Market Volatility: (15%) General market volatility and the stock's recent price fluctuations are causing some uncertainty. - Debt and Valuation Concerns: (10%) The high PE ratio and the mention of debt raise concerns about the company's valuation and financial health. ### Social Dominance: XXXXXXX%  [Social Dominance 24-Hour Time-Series Raw Data](/topic/$alvo/time-series/social_dominance.tsv) Current Value: XXXXXXX% Daily Average: XXXXXXX% X Week: XXXXXX% +0.00019999999999999998% X Month: XXXXXX% -XXXX% X Months: XXXXXX% -XXXXXX% X Year: XXXXXX% +0.0028% 1-Year High: XXXXX% on 2025-01-05 1-Year Low: XXXXXX% on 2025-09-21 ### Market Dominance: XXXXXXX%  [Market Dominance 24-Hour Time-Series Raw Data](/topic/$alvo/time-series/market_dominance.tsv) Current Value: XXXXXXX% Daily Average: X% 1-Year High: XXXXXXX% on 2025-03-12 1-Year Low: XXXXXXX% on 2025-12-02 ### Market Cap: $XXXXXXXXXXXXX  [Market Cap 24-Hour Time-Series Raw Data](/topic/$alvo/time-series/market_cap.tsv) Current Value: $XXXXXXXXXXXXX Daily Average: $XXXXXXXXXXXXX X Week: $XXXXXXXXXXXXX +$19% X Month: $XXXXXXXXXXXXX -$2.60% X Months: $XXXXXXXXXXXXX -$43% X Year: $XXXXXXXXXXXXX -$49% 1-Year High: $XXXXXXXXXXXXX on 2025-01-10 1-Year Low: $XXXXXXXXXXXXX on 2025-12-02 ### Top Alvotech Ordinary Shares Social Posts Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "INITIATIONS ๐น $AER Buy at Truist Secs; PT $XXX ๐น $A Buy at Goldman; PT $XXX ๐น $ALGN Equal Weight at Barclays; PT $XXX ๐น $ALVO Underweight at Barclays; PT $X ๐น $AS Overweight at Barclays; PT $XX ๐น $AAL Market Perform at BMO; PT $XXXXX ๐น $AMRX Overweight at Barclays; PT $XX ๐น $AMPH Equal Weight at Barclays; PT $XX ๐น $ANIP Overweight at Barclays; PT $XXX ๐น $BRKR Sell at Goldman; PT $XX ๐น $CAH Overweight at Barclays; PT $XXX ๐น $COR Overweight at Barclays; PT $XXX ๐น $COLL Overweight at Barclays; PT $XX ๐น $DHR Buy at Goldman; PT $XXX ๐น $DAL Outperform at BMO; PT $XX ๐น $XRAY" [X Link](https://x.com/CHItraders/status/1998367356611879130) [@CHItraders](/creator/x/CHItraders) 2025-12-09T12:21Z 5090 followers, XXX engagements "๐ US Exchanges 52-Week New Lows: $GTLB Gitlab $ACHC Acadia Healthcr $OKTA Okta $LI Li Auto $ NTNX Nutanix $VS Versus Systems $LFMD Lifemd $ALVO Alvotech $CXAI Cxapp $CCRN Cross Ctry Hlthcr $VNRX Volitionrx $AREB American Rebel $AKTX Akari" [X Link](https://x.com/scottlacombe77/status/1996617961571074544) [@scottlacombe77](/creator/x/scottlacombe77) 2025-12-04T16:29Z XX followers, XXX engagements "๐ US Exchanges 52-Week New Lows: $GTLB Gitlab $ACHC Acadia Healthcr $OKTA Okta $LI Li Auto $ NTNX Nutanix $VS Versus Systems $LFMD Lifemd $ALVO Alvotech $CXAI Cxapp $CCRN Cross Ctry Hlthcr $VNRX Volitionrx $AREB American Rebel $AKTX Akari Therapeutics $TEAD Teads Holding CO $LRN Stride #stockinfocus" [X Link](https://x.com/aipatternlab/status/1996303472900096173) [@aipatternlab](/creator/x/aipatternlab) 2025-12-03T19:40Z 4463 followers, XXX engagements "Exome Asset Management Q325 13F Recap: (4/5) Closed: $ABC (call) $ACAD (call) $AKRO (put) $ALT (put) $ALVO $ANAB $APLS $AZN (put) $BCRX $CLDX $CMPS $CRNX $DYN $ELDN $ELEV $FULC (call) $GPCR $LEGN $MREO (put) $NAMS $NKTR (call)" [X Link](https://x.com/seedytx19/status/1992014245467414979) [@seedytx19](/creator/x/seedytx19) 2025-11-21T23:36Z 1340 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Alvotech's stock price has seen a significant decline following an FDA Complete Response Letter for its AVT05 biosimilar and lowered FY25 guidance. This downturn is compounded by negative social media sentiment and recent financial institution downgrades, despite a recent European approval for Gobivaz.
Alvotech Ordinary Shares (ALVO) is a publicly traded stock in the healthcare sector, focused on developing and manufacturing biosimilar medicines.
Alvotech Ordinary Shares uses the ticker $ALVO for trading. Listed in the Stocks category within the Healthcare sectors.
Price 24-Hour Time-Series Raw Data
The stock price has declined significantly due to an FDA Complete Response Letter for its AVT05 biosimilar and lowered FY25 guidance, exacerbated by negative social media sentiment and recent financial institution downgrades, despite recent European approval for Gobivaz.
24-Hour: XXXX% 7-Day: XXXXX% 30-Day: -XXXX%
1-Year High: $XXXXX on 2025-01-11
1-Year Low: $XXXX on 2025-12-02
AltRank 24-Hour Time-Series Raw Data
Alvotech Ordinary Shares (ALVO) is currently AltRank #1,691 based on combined combined social and market metrics
Daily Average: XXXXX
X Week: XXXXX +51
X Month: XXXXX +756
X Months: XXXXX -XXX
X Year: XXXXX +35
1-Year High: XXXXX on 2025-07-30
1-Year Low: XX on 2024-12-29
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX +25
X Month: XX no change
X Months: XX +26
X Year: XX +24
1-Year High: XX on 2025-09-23
1-Year Low: X on 2025-09-03
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXX +178%
X Month: XXXXXX -XX%
X Months: XXXXXXX +132%
X Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2025-08-13
1-Year Low: XX on 2025-04-20
Engagements by network (24h): Reddit: XX X: XXX
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XXX +7.10%
X Month: XXX -X%
X Months: XXXXX +84%
X Year: XXXXX +83%
1-Year High: XXX on 2025-06-30
1-Year Low: X on 2025-12-08
Mentions by network (24h): Reddit: XX X: XX
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Alvotech Ordinary Shares (ALVO) in the last XX hours which is up XX% from X in the previous XX hours
Daily Average: XX
X Week: XX +7.60%
X Month: XXX -XX%
X Months: XXXXX +207%
X Year: XXXXX +144%
1-Year High: XXX on 2025-06-30
1-Year Low: X on 2025-03-02
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% +7%
X Month: XX% -XX%
X Months: XX% -XX%
X Year: XX% +43%
1-Year High: XXX% on 2025-01-27
1-Year Low: X% on 2025-01-19
Most Supportive Themes:
Most Critical Themes:
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXXXX%
X Week: XXXXXX% +0.00019999999999999998%
X Month: XXXXXX% -XXXX%
X Months: XXXXXX% -XXXXXX%
X Year: XXXXXX% +0.0028%
1-Year High: XXXXX% on 2025-01-05
1-Year Low: XXXXXX% on 2025-09-21
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXXXX% on 2025-03-12
1-Year Low: XXXXXXX% on 2025-12-02
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX +$19%
X Month: $XXXXXXXXXXXXX -$2.60%
X Months: $XXXXXXXXXXXXX -$43%
X Year: $XXXXXXXXXXXXX -$49%
1-Year High: $XXXXXXXXXXXXX on 2025-01-10
1-Year Low: $XXXXXXXXXXXXX on 2025-12-02
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"INITIATIONS ๐น $AER Buy at Truist Secs; PT $XXX ๐น $A Buy at Goldman; PT $XXX ๐น $ALGN Equal Weight at Barclays; PT $XXX ๐น $ALVO Underweight at Barclays; PT $X ๐น $AS Overweight at Barclays; PT $XX ๐น $AAL Market Perform at BMO; PT $XXXXX ๐น $AMRX Overweight at Barclays; PT $XX ๐น $AMPH Equal Weight at Barclays; PT $XX ๐น $ANIP Overweight at Barclays; PT $XXX ๐น $BRKR Sell at Goldman; PT $XX ๐น $CAH Overweight at Barclays; PT $XXX ๐น $COR Overweight at Barclays; PT $XXX ๐น $COLL Overweight at Barclays; PT $XX ๐น $DHR Buy at Goldman; PT $XXX ๐น $DAL Outperform at BMO; PT $XX ๐น $XRAY"
X Link @CHItraders 2025-12-09T12:21Z 5090 followers, XXX engagements
"๐ US Exchanges 52-Week New Lows: $GTLB Gitlab $ACHC Acadia Healthcr $OKTA Okta $LI Li Auto $ NTNX Nutanix $VS Versus Systems $LFMD Lifemd $ALVO Alvotech $CXAI Cxapp $CCRN Cross Ctry Hlthcr $VNRX Volitionrx $AREB American Rebel $AKTX Akari"
X Link @scottlacombe77 2025-12-04T16:29Z XX followers, XXX engagements
"๐ US Exchanges 52-Week New Lows: $GTLB Gitlab $ACHC Acadia Healthcr $OKTA Okta $LI Li Auto $ NTNX Nutanix $VS Versus Systems $LFMD Lifemd $ALVO Alvotech $CXAI Cxapp $CCRN Cross Ctry Hlthcr $VNRX Volitionrx $AREB American Rebel $AKTX Akari Therapeutics $TEAD Teads Holding CO $LRN Stride #stockinfocus"
X Link @aipatternlab 2025-12-03T19:40Z 4463 followers, XXX engagements
"Exome Asset Management Q325 13F Recap: (4/5) Closed: $ABC (call) $ACAD (call) $AKRO (put) $ALT (put) $ALVO $ANAB $APLS $AZN (put) $BCRX $CLDX $CMPS $CRNX $DYN $ELDN $ELEV $FULC (call) $GPCR $LEGN $MREO (put) $NAMS $NKTR (call)"
X Link @seedytx19 2025-11-21T23:36Z 1340 followers, XXX engagements
/topic/$alvo